跳至主要内容
临床试验/NCT04227223
NCT04227223已完成不适用

Oxidative- Antioxidative Balance and Cognitive Functions During Opioid Therapy

Medical University of Bialystok1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年9月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
oxidative balance

研究概览

简要总结

The oxidative - antioxidative balance is the crucial mechanism of opioid-induced immunomodulation. Additionally, impairement of cognitive function during opioid therapy is another important side- effect. This phenomenon was clearly described in opioids abuse. This is interesting to evaluate the importance of this subjects in chronic pain patients. The aim of the study was to investigate the oxidative - antioxidative homeostasis and cognitive functions using serum total oxidative capacity (TOC) and total antioxidative capacity (TAC) tests and Brain Derivered Neutrophic Factor (BDNF) in patient with chronic non-cancer pain treated with opioids.

详细描述

The project was approved in Ethical Committee and supported by Medical University of Bialystok (Poland). The serum TOC and TAC measurements were performed in total group of 50 adult patients: Study Group - 36 patients with chronic Low-Back Pain with opioids pharmacotherapy and Control Group - 14 patients, healthy volunteers. In Study Group anthropometric parameters, duration in opioid therapy, type of opioid, total dose, and form of application were registered.TOC, TAC, and BDNF measurements were performed using ImAnOx, PerOx, BDNF tests (Immundiagnostik, Germany).Data were analyzed using non-parametric tests.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •minimally, 6 months opioid therapy in chronic Low- Back Pain

排除标准

  • •depression, steroids- local or systemic administration

研究组 & 干预措施

Study Group

Experimental

Study Group - 36 patients with chronic Low-Back Pain with opioids pharmacotherapy

干预措施: biochemical measurements (Diagnostic Test)

Control Group

Active Comparator

Control Group - 14 patients, healthy volunteers.

干预措施: biochemical measurements (Diagnostic Test)

结局指标

主要结局

oxidative balance

时间窗: 6 months of opioids therapy

measurements of total oxidative capacity and total antioxidative capacity

cognitive state

时间窗: 6 months of opioids therapy

measurements of Brain-derived Neurotrophic Function

次要结局

未报告次要终点

研究者

发起方
Medical University of Bialystok
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验